{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:08:38Z","timestamp":1759410518337,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.vaccine.2014.10.024","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T18:56:32Z","timestamp":1414608992000},"page":"7141-7147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children"],"prefix":"10.1016","volume":"32","author":[{"given":"Rebecca C.","family":"Brady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vonda G.","family":"Houchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank S.","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter F.","family":"Hartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne C.","family":"Sawlwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank R.","family":"Albano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.10.024_bib0005","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.vaccine.2008.05.024","article-title":"Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine","volume":"26","author":"Talbot","year":"2008","journal-title":"Vaccine"},{"year":"2007","series-title":"Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines","author":"United States Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research","key":"10.1016\/j.vaccine.2014.10.024_bib0010"},{"year":"2009","series-title":"Vaccines and related biological products advisory committee meeting presentations","author":"United States Department of Health and Human Services, Food and Drug Administration","key":"10.1016\/j.vaccine.2014.10.024_bib0015"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajcp\/92.4.487","article-title":"Successful use of shell vial centrifugation and 16 to 18-hour immunofluorescent staining for the detection of influenza A and B in clinical specimens","volume":"92","author":"Bartholoma","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.33321\/cdi.2009.33.40","article-title":"Annual report: surveillance of adverse events following immunisation in Australia, 2008","volume":"33","author":"Menzies","year":"2009","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0030","unstructured":"World Health Organization. Recommendations for influenza vaccine composition. Available at: (http:\/\/www.who.int\/influenza\/vaccines\/vaccinerecommendations1\/en\/index3.html) (Accessed July 5, 2014)."},{"key":"10.1016\/j.vaccine.2014.10.024_bib0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/irv.12107","article-title":"Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children, and adolescents","volume":"7","author":"Lambert","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"year":"2010","series-title":"Seasonal flu vaccine and young children","author":"Australian Government Department of Health and Ageing","key":"10.1016\/j.vaccine.2014.10.024_bib0040"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2014.10.024_bib0045","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1136\/bmjopen-2010-000016","article-title":"Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine","volume":"1","author":"Armstrong","year":"2011","journal-title":"BMJ Open"},{"year":"2010","series-title":"Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children","author":"Australian Government Department of Health and Ageing. Therapeutic Goods Administration","key":"10.1016\/j.vaccine.2014.10.024_bib0050"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0055","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old","volume":"296","author":"Hambidge","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0060","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1016\/j.vaccine.2009.05.023","article-title":"Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6\u201323 months of age","volume":"27","author":"Rosenberg","year":"2009","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2014.10.024_bib0065","first-page":"989","article-title":"Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of, CSL., seasonal influenza vaccine (AFLURIA) in the United States during, 2010\u201311","volume":"59","author":"Centers for Disease Control and, Prevention","year":"2010","journal-title":"MMWR, Morb Mortal Wkly Rep"},{"year":"2011","series-title":"Approval letter-AFLURIA 2011\/2012 formulation","author":"United States Department of Health and Human Services, Food and Drug Administration","key":"10.1016\/j.vaccine.2014.10.024_bib0070"},{"issue":"32","key":"10.1016\/j.vaccine.2014.10.024_bib0075","first-page":"613","article-title":"Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)\u2014United States, 2012\u201313 influenza, season","volume":"61","author":"Centers for Disease Control and, Prevention","year":"2012","journal-title":"MMWR, Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0080","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1016\/j.vaccine.2012.09.083","article-title":"Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere trivalent influenza vaccine","volume":"30","author":"Maraskovsky","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0085","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.vaccine.2014.03.032","article-title":"Evaluation of the bioactivity of influenza vaccine strains in vitro in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events","volume":"32","author":"Rockman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0090","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.vaccine.2014.03.035","article-title":"Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine","volume":"32","author":"Rockman","year":"2014","journal-title":"Vaccine"},{"year":"2010","series-title":"Excipients in vaccines","author":"Institute for Vaccine Safety","key":"10.1016\/j.vaccine.2014.10.024_bib0095"},{"key":"10.1016\/j.vaccine.2014.10.024_bib0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0264-410X(98)90040-8","article-title":"Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population","volume":"2","author":"Tannock","year":"1984","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:18Z","timestamp":1759400478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14013991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":20,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0264410X14013991"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}